175 related articles for article (PubMed ID: 25478319)
1. Genome-wide redistribution of BRD4 binding sites in transformation resistant cells.
Si H; Scaffidi P; Merchant A; Cam M; Stahlberg E; Misteli T; Fernandez P
Genom Data; 2015 Mar; 3():33-35. PubMed ID: 25478319
[TBL] [Abstract][Full Text] [Related]
2. Transformation resistance in a premature aging disorder identifies a tumor-protective function of BRD4.
Fernandez P; Scaffidi P; Markert E; Lee JH; Rane S; Misteli T
Cell Rep; 2014 Oct; 9(1):248-260. PubMed ID: 25284786
[TBL] [Abstract][Full Text] [Related]
3. Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome.
Díez-Díez M; Amorós-Pérez M; de la Barrera J; Vázquez E; Quintas A; Pascual-Figal DA; Dopazo A; Sánchez-Cabo F; Kleinman ME; Gordon LB; Fuster V; Andrés V; Fuster JJ
Geroscience; 2023 Apr; 45(2):1231-1236. PubMed ID: 35752705
[TBL] [Abstract][Full Text] [Related]
4. Hutchinson-Gilford Progeria Syndrome (Hgps) and Application of Gene Therapy Based Crispr/Cas Technology as A Promising Innovative Treatment Approach.
Rajeev M; Ratan C; Krishnan K; Vijayan M
Recent Pat Biotechnol; 2021; 15(4):266-285. PubMed ID: 34602042
[TBL] [Abstract][Full Text] [Related]
5. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
[TBL] [Abstract][Full Text] [Related]
6. Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson-Gilford progeria syndrome fibroblasts.
Bikkul MU; Clements CS; Godwin LS; Goldberg MW; Kill IR; Bridger JM
Biogerontology; 2018 Dec; 19(6):579-602. PubMed ID: 29907918
[TBL] [Abstract][Full Text] [Related]
7. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
8. Microbiome at sites of gingival recession in children with Hutchinson-Gilford progeria syndrome.
Bassir SH; Chase I; Paster BJ; Gordon LB; Kleinman ME; Kieran MW; Kim DM; Sonis A
J Periodontol; 2018 Jun; 89(6):635-644. PubMed ID: 29520806
[TBL] [Abstract][Full Text] [Related]
9. The Molecular and Cellular Basis of Hutchinson-Gilford Progeria Syndrome and Potential Treatments.
Batista NJ; Desai SG; Perez AM; Finkelstein A; Radigan R; Singh M; Landman A; Drittel B; Abramov D; Ahsan M; Cornwell S; Zhang D
Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980874
[TBL] [Abstract][Full Text] [Related]
10. Impaired LEF1 Activation Accelerates iPSC-Derived Keratinocytes Differentiation in Hutchinson-Gilford Progeria Syndrome.
Mao X; Xiong ZM; Xue H; Brown MA; Gete YG; Yu R; Sun L; Cao K
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628310
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetic insights into the ageing syndrome Hutchinson-Gilford Progeria (HGPS).
Corso C; Parry EM; Faragher RG; Seager A; Green MH; Parry JM
Cytogenet Genome Res; 2005; 111(1):27-33. PubMed ID: 16093717
[TBL] [Abstract][Full Text] [Related]
12. Hutchinson-Gilford progeria syndrome as a model for vascular aging.
Brassard JA; Fekete N; Garnier A; Hoesli CA
Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290
[TBL] [Abstract][Full Text] [Related]
13. Genomic instability and DNA damage responses in progeria arising from defective maturation of prelamin A.
Musich PR; Zou Y
Aging (Albany NY); 2009 Jan; 1(1):28-37. PubMed ID: 19851476
[TBL] [Abstract][Full Text] [Related]
14. Rescue of Mitochondrial Function in Hutchinson-Gilford Progeria Syndrome by the Pharmacological Modulation of Exportin CRM1.
Monterrubio-Ledezma F; Navarro-García F; Massieu L; Mondragón-Flores R; Soto-Ponce LA; Magaña JJ; Cisneros B
Cells; 2023 Jan; 12(2):. PubMed ID: 36672210
[TBL] [Abstract][Full Text] [Related]
15. Progeria and Aging-Omics Based Comparative Analysis.
Caliskan A; Crouch SAW; Giddins S; Dandekar T; Dangwal S
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289702
[TBL] [Abstract][Full Text] [Related]
16. SerpinE1 drives a cell-autonomous pathogenic signaling in Hutchinson-Gilford progeria syndrome.
Catarinella G; Nicoletti C; Bracaglia A; Procopio P; Salvatori I; Taggi M; Valle C; Ferri A; Canipari R; Puri PL; Latella L
Cell Death Dis; 2022 Aug; 13(8):737. PubMed ID: 36028501
[TBL] [Abstract][Full Text] [Related]
17. Progerin-Induced Replication Stress Facilitates Premature Senescence in Hutchinson-Gilford Progeria Syndrome.
Wheaton K; Campuzano D; Ma W; Sheinis M; Ho B; Brown GW; Benchimol S
Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28483909
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
[TBL] [Abstract][Full Text] [Related]
19. Vascular smooth muscle cell loss underpins the accelerated atherosclerosis in Hutchinson-Gilford progeria syndrome.
Hamczyk MR; Andrés V
Nucleus; 2019 Dec; 10(1):28-34. PubMed ID: 30900948
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
